SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Trimurthi informs about update on outcome of board meeting

10 Aug 2023 Evaluate

Trimurthi has informed that, Aditya Bhangadia has been appointed as an additional director (Managing director) with effect from 09.08.2023 and Ravi Bhangadia as Chairman and an Additional Director (Whole time director) with effect from 09.08.2023. In the outcome, the designation of the directors were inadvertently interchanged.

The above information is a part of company’s filings submitted to BSE.

Novelix Pharma Share Price

54.20 -1.94 (-3.46%)
20-Apr-2026 14:32 View Price Chart
Peers
Company Name CMP
Redington 227.95
Adani Enterprises 2249.10
Amrapali Industries 17.99
Rashi Peripheral 474.85
PDS 293.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×